Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Syra Health Expects FY24 Revenue Of $9M-$11M Vs $10.64M Est

Author: Benzinga Newsdesk | March 25, 2024 08:48am

2024 Financial Outlook

The Company expects full-year 2024 revenue of $9 to $11 million, representing a growth of 64%-100% versus 2023.
- Guidance does not include any potential revenues from Caduceus Healthcare with regards to the recently announced Federal Influx Care Facilities contract.

Posted In: SYRA